Invesco Biotechnology & Genome ETF
PBE
PBE
100 hedge funds and large institutions have $92.8M invested in Invesco Biotechnology & Genome ETF in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 28 increasing their positions, 24 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 102 → 100 (-2)
Holders
100
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$16.8M | |
| 2 | +$669K | |
| 3 | +$519K | |
| 4 |
OCM
One Capital Management
Westlake Village,
California
|
+$398K |
| 5 |
IWM
IHT Wealth Management
Chicago,
Illinois
|
+$364K |
Top Sellers
| 1 | -$2.11M | |
| 2 | -$721K | |
| 3 | -$425K | |
| 4 |
CW
CreativeOne Wealth
Overland Park,
Kansas
|
-$356K |
| 5 |
Two Sigma Investments
New York
|
-$324K |